hVIVO’s Dr Nicolas Noulin making oral presentation at World Vaccine Congress (“WVC 2018”), Washington DC USA, April

March 16, 2018 3:28 am

WVC 2018, 03-05 April 2018, Renaissance Washington DC Downtown Hotel, Washington DC, USA 

Dr Nicolas Noulin, hVIVO’s Associate Director, Scientific Operations, will be making an oral presentation at WVC 2018 in addition to hVIVO being a Gold Sponsor of the event, this the 18th in the series. The event takes place between 3rd and 5th April 2018 in Washington DC, USA.

  • Dr Noulin’s hVIVO oral presentation, “Utilizing Human Challenge Studies to Accelerate the Development of Respiratory Vaccines” takes place on Day 2, April 4th at 3:10 and will give insight in considerations for study design, setting the stage for field studies, and how hVIVO human disease models and viral challenge studies can help you accelerate vaccine development.

In addition to the hVIVO oral presentation we invite you to stop by our booth (number 318) to learn more about hVIVO and how our human disease models in flu, RSV and asthma can help you accelerate vaccine development.

If you would like to make contact with Dr Nicolas Noulin, Rich Niemi, Senior Business Development Director, Anthony Gilbert, Medical director, from hVIVO before or during the WVC event in Washington DC, please use the Contact Us page on this site. hVIVO will be present on Stand 318 in the exhibition display area.

Find out more about WVC 2018 here: https://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm .

Comments are closed here.